The cholestanol content of a cataractous lens nucleus from a patient with cerebrotendinous xanthomatosis (CTX) was quantified by gas chromatography-mass spectrometry and found to be 027 [ig per mg freeze-dried lens tissue.
Cerebrotendinous xanthomatosis (Cl caused by a rare inborn error of bi synthesis.' Its main clinical features cataracts, tendon xanthomata, and neur' abnormalities, which usually first apparent during the second and third dec life.2 The biochemical defect lies in hyd tion of the steroid side-chain of cho (5-cholesten-313-ol), prior to oxidative cl which occurs during hepatic conversion t and chenodeoxycholic acids (Fig 1) Standards were prepared from known amounts of cholestanol and a fixed amount of cholesterol and cholestane subject to the same saponification procedure. A standard curve was plotted relating the cholestanol content of the standard samples to the cholestanol/cholestane area ratio. The amount of cholestanol in the lens nucleus samples was estimated from this standard curve by means of the calculated cholestanol/cholestane ratio of the unknown lens sample. The free sterol peaks, but not internal standard, overlapped in the gas chromatography D R=H trace. Because of this the cholestanol component was estimated from the GC-MS peak with mass-charge ratio of 388 after compensation for the cholesterol component. The cholesterol component of the peak at 388 was calculated from the peak at 386 by means of the ratio 
